Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, Singapore, and internationally. The company offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter or a program administrator with delegated authority from insurance carriers. It serves commercial, industrial, institutional, individual, and government sectors.
Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →
| Cuenta de resultados | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Ingresos totales | $3.2B | $3.1B | $2.5B | $2.1B | $1.7B | $1.4B | $1.0B | $765M |
| Beneficio bruto | — | $2.8B | $2.5B | $2.1B | $1.7B | $1.4B | $1.0B | $765M |
| % de margen bruto | — | 90.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Ingresos operativos (EBIT) | — | $625M | $273M | $238M | $179M | $62M | $79M | $68M |
| % de margen operativo | — | 20.5% | 10.8% | 11.5% | 10.4% | 4.3% | 7.8% | 8.9% |
| Ingresos netos | — | $63M | $95M | $61M | $61M | $66M | $68M | $64M |
| % de margen neto | — | 2.1% | 3.8% | 2.9% | 3.5% | 4.6% | 6.7% | 8.4% |
| EBITDA | — | $803M | $599M | $473M | $393M | $254M | $194M | $157M |
| Beneficio por acción (EPS) | — | $0.23 | $0.34 | $0.22 | $0.23 | $0.62 | $0.64 | $0.60 |
| Acciones en circulación (M) | — | 279M | 276M | 272M | 270M | 106M | 106M | 106M |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de RYAN. /companies/us/RYAN
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms